A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above
Clinical trial NCT06645665 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06645665
- Sponsor
- Shenzhen Shenxin Biotechnology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2027-04-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.